Heron Therapeutics, Inc. (HRTX) is a publicly traded Healthcare sector company. As of May 21, 2026, HRTX trades at $0.86 with a market cap of $162.67M and a P/E ratio of -5.01. HRTX moved +0.18% today. Year to date, HRTX is -31.85%; over the trailing twelve months it is -55.98%. Its 52-week range spans $0.74 to $2.68. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces HRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Heron Therapeutics, Inc. (HRTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. HRTX moved +0.18% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $162.67M |
| P/E Ratio | -5.01 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.68 |
| 52-Week Low | $0.74 |
| Volume | 2.04M |
| Avg Volume | 0 |
| Revenue (TTM) | $150.71M |
| Net Income | $-30.94M |
| Gross Margin | 71.12% |
2 analysts cover HRTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.